Showing results (161-170 of 292) with videos related to
Sort By:
Pageof 30
Vascular and Endovascular Surgery|June 27, 2009
Inflammatory abdominal aortic aneurysms (IAAA): past and presentSharath C V Paravastu, David Murray, Jonathan Ghosh, et al.Experimental Hematology|June 13, 2012
Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell linesBenigno C Valdez, Yago Nieto, David Murray, et al.Journal of Graduate Medical Education|October 7, 2011
Creating and evaluating a data-driven curriculum for central venous catheter placementJames R Duncan, Katherine Henderson, Mandie Street, et al.Leukemia & Lymphoma|April 11, 2017
The PARP inhibitor olaparib enhances the cytotoxicity of combined gemcitabine, busulfan and melphalan in lymphoma cellsBenigno C Valdez, Yang Li, David Murray, et al.Acta Orthopaedica|June 24, 2014
The influence of hip rotation on femoral offset in plain radiographsPhilipp Lechler, Michael Frink, Aashish Gulati, et al.Blood Advances|December 1, 2025
Engraftment of gene-edited hematopoietic stem cells after antibody-drug conjugate conditioning in nonhuman primatesJason David Murray, Teresa K Einhaus, Stefan Radtke, et al.Oncotarget|March 14, 2024
ABT199/venetoclax synergism with thiotepa enhances the cytotoxicity of fludarabine, cladribine and busulfan in AML cellsBenigno C Valdez, Bin Yuan, David Murray, et al.Oncotarget|February 10, 2018
Combination of a hypomethylating agent and inhibitors of PARP and HDAC traps PARP1 and DNMT1 to chromatin, acetylates DNA repair proteins, down-regulates NuRD and induces apoptosis in human leukemia and lymphoma cellsBenigno C Valdez, Yang Li, David Murray, et al.Leukemia & Lymphoma|October 26, 2011
Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and suberoylanilide hydroxamic acid in lymphoma cell linesBenigno C Valdez, David Murray, Yago Nieto, et al.Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.Pageof 30